Recently, Marco Hannappel, President of Phillip Morris International (PMI) in Southwest Europe, stated that approximately two million smokers in Italy have switched to using IQOS.
We are rapidly advancing towards the goal of a 'smoke-free future' by providing adult smokers with higher technological alternatives," said Marco Hannappel.
The 2022 PMI annual report reveals that the shipment volume of heated tobacco products (HTP) in Italy reached 1.23 million units, representing a 37.7% YoY growth. Italy has become PMI's largest market for HTP in Europe, second only to Russia.
According to Gianluca Iannelli, the marketing and digital director of PMI Italy, the company has recently launched a new product called IQOS Iluma One in the Italian market. PMI aims to use this product to convince even the most stubborn smokers to change their lifestyle and switch to a simpler and more intuitive device.
Reference: [1] Philip Morris International Inc. (PMI) has released its financial results for the fourth quarter and full-year of 2022.
According to a report, two million smokers in Italy have switched to using IQOS.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
